Biotech Values

[Double_Bagel]

Personalized Diagnostic Medicine Coming of Age

http://beta.fool.com/streetwisereport/2012/12/06/personalized-diagnostic-medicine-coming-age/18246/?ticker=OPK&source=eogyholnk0000001

If you had to choose between GHDX, EXAS or OPK which which one would you choose?

I think Dew likes EXAS enough to select it as a pick in the 2013 Biotech charity contest. But does he like it enough to put real money into it at this price?

They all seem over-valued tremendously. Is the potential so great for future earnings that people are paying up now?

How do we know that this won't be another MAKO which was trading at the mid-40s and now struggling to stay over 11?

Finally, is there room for more than one winner in this field?

Thanks.